Price Alert

Immunome Inc. (IMNM)

NASDAQ: IMNM · Real-Time Price · USD

10.26

0.32 (3.22%)

At close: Aug 15, 2025, 3:59 PM

10.40

1.41%

After-hours: Aug 15, 2025, 06:45 PM EDT

Immunome Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	143.88M	257.61M	143.35M	155.57M	165.33M	269.72M	98.68M	90.64M	38.42M	44.42M	20.32M	27.08M	34.65M	42.88M	49.23M	56.24M	59.83M	36.28M
Short-Term Investments	124.16M	59.71M	73.95M	84.56M	113.02M	39.98M	39.46M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K
Other Long-Term Assets	4.56M	4.45M	4.51M	3.2M	3.21M	568K	100K	130K	432K	332K	332K	332K	332K	382K	332K	307K	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	289K	n/a	208K	821K	847K	1.09M	1.09M	795K	4.31M	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-208K	-821K	-847K	n/a	n/a	n/a	-4.31M	n/a	-1.7M	-2.6M
Other Current Assets	9.4M	5.81M	4.04M	3.91M	n/a	n/a	4.99M	416K	1.11M	2.11M	2.33M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	277.43M	323.13M	221.34M	244.04M	284.28M	313.33M	144.7M	91.41M	39.53M	46.54M	22.65M	29.24M	37.6M	46.3M	56.64M	61.19M	62.81M	41.11M
Property-Plant & Equipment	14.29M	15.12M	14.39M	9.56M	8.62M	5.76M	3.64M	1.52M	1.38M	1.15M	965K	875K	989K	943K	855K	961K	1.23M	1.39M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	18.86M	19.56M	18.9M	12.86M	11.93M	6.43M	3.84M	1.75M	1.91M	1.58M	1.4M	1.31M	1.42M	1.43M	1.29M	1.37M	1.33M	1.49M
Total Assets	296.29M	342.69M	240.24M	256.9M	296.21M	319.75M	148.54M	93.16M	41.44M	48.11M	24.05M	30.55M	39.02M	47.73M	57.92M	62.56M	64.14M	42.59M
Account Payables	4.66M	9.13M	14.19M	3.52M	7.05M	7.18M	3.31M	2.79M	3.7M	3.31M	2.4M	3.14M	5.26M	3.89M	3.08M	3.28M	1.79M	2.96M
Deferred Revenue	n/a	4.01M	6.94M	9.68M	12.59M	12.74M	10.49M	16.96M	17.67M	18.21M	n/a	n/a	n/a	n/a	-317K	4.38M	n/a	n/a
Short-Term Debt	n/a	n/a	63K	257K	295K	419K	310K	228K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	16K	44K	444K
Other Current Liabilities	6.82M	4.2M	7.93M	25.82M	17.32M	8.97M	4.67M	1.69M	907K	827K	1.96M	1.39M	954K	1.43M	3.27M	3.37M	1.03M	914K
Total Current Liabilities	22.88M	30.8M	54.31M	39.53M	39.9M	30.77M	21.83M	23.11M	26.39M	24.83M	7.33M	7.37M	8.62M	9.71M	9.73M	7.76M	3.52M	4.57M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	134K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	5.49M	61M	n/a	n/a	n/a	n/a	n/a	n/a	12K	n/a	3K	5K
Total Long-Term Liabilities	4.14M	4.77M	4.77M	2.46M	2.48M	3.41M	6.83M	63.97M	5.71M	9.42M	62K	93K	124K	147K	12K	n/a	3K	139K
Total Liabilities	27.02M	35.57M	59.08M	41.99M	42.38M	34.18M	28.66M	87.08M	32.1M	34.25M	7.39M	7.46M	8.74M	9.85M	9.74M	7.76M	3.52M	4.71M
Total Debt	4.14M	4.77M	4.83M	2.72M	2.77M	1.63M	1.65M	371K	489K	236K	293K	184K	190K	208K	317K	16K	44K	578K
Common Stock	9K	9K	6K	6K	6K	6K	4K	1K	1K	1K	1K	1K	1K	1K	1K	1K	1K	1K
Retained Earnings	-600.81M	-557.41M	-515.77M	-435.52M	-388.42M	-352.3M	-222.81M	-130.17M	-125.83M	-120.27M	-116M	-108.22M	-99.68M	-90.76M	-79.11M	-71.25M	-63.53M	-58.29M
Comprehensive Income	-24K	-3K	57K	70K	2K	4K	22K	n/a	0.00	n/a	0.00	n/a	n/a	n/a	0.00	n/a	n/a	n/a
Shareholders Equity	269.27M	307.13M	181.16M	214.91M	253.84M	285.57M	119.88M	6.08M	9.34M	13.86M	16.65M	23.08M	30.28M	37.87M	48.19M	54.79M	60.62M	37.88M
Total Investments	124.16M	59.71M	73.95M	84.56M	113.12M	40.08M	39.56M	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K